Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes.

Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes.

AIMS: Missed diagnosis of maturity-onset diabetes of the young (MODY) has led to an interest in biomarkers that enable efficient prioritization of patients for definitive molecular testing. Apolipoprotein M (apoM) was suggested as a biomarker for hepatocyte nuclear factor 1 alpha (HNF1A)-MODY becaus...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	Mughal, SA, Park, R, Nowak, N, Gloyn, A, Karpe, F, Matile, H, Malecki, M, McCarthy, M, Stoffel, M, Owen, K
Materialtyp:	Journal article
Språk:	English
Publicerad:	2013

Liknande verk

No attenuation of CRP response to acute inflammation is seen in HNF1A-MODY
av: Owen, K, et al.
Publicerad: (2013)

HNF1A-MODY is associated with an intact CRP response during human endotoxaemia
av: Mughal, SA, et al.
Publicerad: (2014)

High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
av: McDonald, T, et al.
Publicerad: (2011)

High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
av: McDonald, T, et al.
Publicerad: (2011)

Altered cortisol metabolism in individuals with HNF1A-MODY
av: Juszczak, A, et al.
Publicerad: (2020)

Lipoprotein composition in HNF1A-MODY: differentiating between HNF1A-MODY and type 2 diabetes.
av: McDonald, T, et al.
Publicerad: (2012)

Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.
av: Owen, K, et al.
Publicerad: (2010)

Cystatin C is not a good candidate biomarker for HNF1A-MODY.
av: Nowak, N, et al.
Publicerad: (2013)

Cystatin C is not a good candidate biomarker for HNF1A-MODY
av: Nowak, N, et al.
Publicerad: (2013)

Response to Comment on: McDonald et al. High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes. Diabetes Care 2011;34:1860-1862.
av: McDonald, T, et al.
Publicerad: (2011)

Variants influencing age at diagnosis of HNF1A-MODY
av: Agnieszka H. Ludwig-Słomczyńska, et al.
Publicerad: (2022-09-01)

Keeping diabetes in the family: Lessons from a family with HNF-1α MODY
av: Selwood, M, et al.
Publicerad: (2008)

Species-specific differences in the expression of the HNF1A, HNF1B and HNF4A genes.
av: Harries, L, et al.
Publicerad: (2009)

Plasma fucosylated glycans and C-reactive protein as biomarkers of HNF1A-MODY in young adult–onset nonautoimmune diabetes
av: Juszczak, A, et al.
Publicerad: (2018)

Species-specific differences in the expression of the HNF1A, HNF1B and HNF4A genes.
av: Lorna W Harries, et al.
Publicerad: (2009-11-01)

Identification and assessment of glycan profiles as a biomarker for maturity onset diabetes of the young (MODY) due to hepatocyte nuclear factor 1 alpha (HNF1A) mutations
av: Gloyn, A, et al.
Publicerad: (2011)

Lipid profile indices in young people with GCK-MODY and HNF1A-MODY
av: Alla K. Ovsyannikova, et al.
Publicerad: (2022-01-01)

Novel insights into genetics and clinics of the HNF1A-MODY
av: Valkovicova Terezia, et al.
Publicerad: (2019-04-01)

Circulating CD36 is reduced in HNF1A-MODY carriers.
av: Siobhan Bacon, et al.
Publicerad: (2013-01-01)

Maturity onset diabetes of the young due to HNF1A variants in Croatia
av: Pavić, T, et al.
Publicerad: (2018)

Evaluation of high sensitivity C-reactive protein as a screening tool for detecting young South Asians with maturity-onset diabetes of the young due to HNF1A mutations
av: Mughal, SA, et al.
Publicerad: (2013)

Low frequency variants in the exons only encoding isoform A of HNF1A do not contribute to susceptibility to Type 2 diabetes
av: Jafar-Mohammadi, B, et al.
Publicerad: (2009)

Low frequency variants in the exons only encoding isoform A of HNF1A do not contribute to susceptibility to type 2 diabetes.
av: Jafar-Mohammadi, B, et al.
Publicerad: (2009)

Early Onset of Mody5 Due to Haploinsufficiency of HNF1B
av: Carmen Bustamante, MD, et al.
Publicerad: (2020-09-01)

Granuloma annulare and necrobiosis lipoidica in a patient with HNF1A-MODY
av: Gabriela Irene Garcia Brandes, et al.
Publicerad: (2022-05-01)

Role of low frequency variants in HNF1A exons 8-10 encoding hepatocyte nuclear factor-1 alpha isoform A to susceptibility to Type 2 diabetes
av: Jafar-Mohammadi, B, et al.
Publicerad: (2010)

Assessment of the pathogenicity of the previously reported D526N Hepatocyte Nuclear factor-1 alpha (HNF1A) variant using a combined genetic, in silico and functional approach
av: Hassanali, N, et al.
Publicerad: (2013)

Use of high sensitivity C-reactive protein and DG9-glycan index for differential diagnosis of maturity-onset diabetes of the young due to HNF1A mutations in young adults
av: Mughal, SA, et al.
Publicerad: (2013)

Hnf1alpha (MODY3) controls tissue-specific transcriptional programs and exerts opposed effects on cell growth in pancreatic islets and liver.
av: Servitja, J, et al.
Publicerad: (2009)

Severe preeclampsia and gene mutation HNF4A (MODY1): а case report
av: V. M. Gur'eva, et al.
Publicerad: (2018-08-01)

Description of clinical cases of the familial form of diabetes mellitus HNF1A-MODY
av: A. A. Baranova, et al.
Publicerad: (2021-06-01)

Incidence of HNF1A and GCK MODY Variants in a South African Population
av: Matsha TE, et al.
Publicerad: (2020-12-01)

Low frequency variants in the exons only encoding isoform A of HNF1A do not contribute to susceptibility to type 2 diabetes.
av: Bahram Jafar-Mohammadi, et al.
Publicerad: (2009-08-01)

Identification of a novel hepatocyte nuclear factor-1 alpha (HNF1A) variant in maturity onset diabetes of the young type 3 (HNF1A-MODY)
av: Megha Verma, et al.
Publicerad: (2022-04-01)

Semaglutide as a potential therapeutic alternative for HNF1B-MODY: a case study
av: Angham Almutair, et al.
Publicerad: (2024-03-01)

Mutations in the HNF1A gene as a cause of MODY3: a clinical case
av: T. Yu. Demidova, et al.
Publicerad: (2019-05-01)

MODY probability calculator for GCK and HNF1A screening in a multiethnic background population
av: Roberta Magalhães Tarantino, et al.

Comparison of Glomerular Filtration Rate Estimation from Serum Creatinine and Cystatin C in HNF1A-MODY and Other Types of Diabetes
av: Magdalena Szopa, et al.
Publicerad: (2015-01-01)

An Atypical HNF4A Mutation Which Does Not Conform to the Classic Presentation of HNF4A-MODY
av: Andrew J. Spiro, et al.
Publicerad: (2018-01-01)

The role of the HNF4alpha enhancer in type 2 diabetes.
av: Mitchell, S, et al.
Publicerad: (2002)